Foghorn Therapeutics Inc. layoffs
Yes. Foghorn Therapeutics Inc. has filed 1 SEC 8-K with Item 2.05 (exit or disposal costs) since 2023. The most recent, on Oct 1, 2026, described a cut of about 40% of its workforce.
Check FHTX layoff riskSEC filings since 2023
- Oct 12026
Foghorn Therapeutics to cut about 65 jobs (40% of workforce)
Foghorn Therapeutics Inc. (FHTX) · filed 6 weeks agoOn September 25, 2026, following review of clinical data from the Phase 1 trial of FHD-909, Foghorn Therapeutics Inc. (the "Company") and Eli Lilly and Company ("Lilly") made the decision not to advance the trial into the expansion phase.
Get this data via API
Pull layoff filings, risk scores, and WARN notices into your own product. Starts at $49/mo.